USANA Health Sciences, Inc. USNA

14.50 0.24 1.68% as of 25 Sep

Market cap: $263.5M
P/E: 0.0×

Follow USNA

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25
Revenue	1,006.08	1,047.27	1,189.25	1,060.90	1,134.64	1,186.46	998.60	921.01	854.50	925.26
Revenue Growth	9.54%	4.09%	13.56%	(10.79%)	6.95%	4.57%	(15.83%)	(7.77%)	(7.22%)	8.28%
Cost of Revenue	180.19	179.40	200.71	187.50	209.11	217.90	193.89	176.69	161.21	200.85
Gross Profit	825.89	867.86	988.54	873.40	925.53	968.57	804.71	744.32	693.29	724.41
SG&A Expenses	687.27	735.36	800.19	727.21	749.04	798.37	697.10	651.25	626.97	680.01
Operating Income	138.62	132.50	188.35	146.19	176.49	170.19	107.61	93.07	66.32	37.43
Non-operating Income/Expense	(0.07)	2.14	3.16	4.31	1.46	0.45	1.01	9.38	10.03	4.10
Non-operating Interest Expenses	0.44	0.05	0.04	0.07	0.51	0.06	0.19	0.26	0.28	0.84
EBT	138.55	134.64	191.51	150.50	177.95	170.64	108.62	102.45	76.35	41.53
Income Tax Provision	38.51	72.11	65.29	49.97	53.28	54.14	39.27	38.67	34.29	30.05
Income after Tax	100.04	62.54	126.22	100.53	124.66	116.51	69.35	63.79	42.06	11.48
Dividends (Preferred)	—	0.00	0.00	—	0.00	0.00	0.00	0.00	0.00	—
Non-Controlling Interest	—	—	—	—	—	—	—	—	0.03	0.72
Net Income Common	100.04	62.54	126.22	100.53	124.66	116.51	69.35	63.79	42.03	10.76
EPS (Basic)	3.99	2.53	5.12	4.41	5.86	5.73	3.59	3.30	2.19	0.58
EPS (Diluted)	3.99	2.53	5.12	4.41	5.86	5.73	3.59	3.30	2.19	0.58
Shares (Basic, Weighted)	24.19	24.35	24.11	22.64	21.16	20.15	19.25	19.25	19.10	18.54
Shares (Diluted, Weighted)	25.05	24.71	24.64	22.82	21.26	20.34	19.31	19.35	19.16	18.57
Gross Margin	82.09%	82.87%	83.12%	82.33%	81.57%	81.63%	80.58%	80.82%	81.13%	78.29%
EBIT Margin	13.78%	12.65%	15.84%	13.78%	15.55%	14.34%	10.78%	10.11%	7.76%	4.05%
EBT margin	13.77%	12.86%	16.10%	14.19%	15.68%	14.38%	10.88%	11.12%	8.94%	4.49%
Net Profit Margin	9.94%	5.97%	10.61%	9.48%	10.99%	9.82%	6.94%	6.93%	4.92%	1.16%
Free Cash Flow Margin	10.36%	10.56%	11.86%	10.39%	12.81%	9.14%	9.36%	6.10%	5.97%	1.34%
EBITDA	152.10	148.61	205.20	169.20	199.00	192.38	129.02	113.47	88.55	77.13
EBIT	138.62	132.50	188.35	146.19	176.49	170.19	107.61	93.07	66.32	37.43
Income from Continuous Operations	100.04	62.54	126.22	100.53	124.66	116.51	69.35	63.79	42.06	11.48
Consolidated Net Income/Loss	100.04	62.54	126.22	100.53	124.66	116.51	69.35	63.79	42.06	11.48
EPS (Basic, from Continuous Ops)	4.14	2.57	5.24	4.44	5.89	5.78	3.60	3.31	2.20	0.62
EPS (Basic, Consolidated)	4.14	2.57	5.24	4.44	5.89	5.78	3.60	3.31	2.20	0.62
EPS (Diluted, from Cont. Ops)	3.99	2.53	5.12	4.41	5.86	5.73	3.59	3.30	2.20	0.62
Shares (Diluted, Average)	25.05	24.71	24.64	22.82	21.26	20.34	19.31	19.35	19.16	18.57
EPS (Diluted, Consolidated)	3.99	2.53	5.12	4.41	5.86	5.73	3.59	3.30	2.20	0.62
EBITDA Margin	15.12%	14.19%	17.25%	15.95%	17.54%	16.21%	12.92%	12.32%	10.36%	8.34%
Operating Cash Flow Margin	13.61%	11.82%	12.79%	11.95%	14.14%	10.22%	10.40%	7.67%	7.14%	2.42%

Show all line items

In millions of $ except per-share values · columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

USANA Health Sciences, Inc. USNA